Neurogenic inflammation triggered by extravasation of plasma protein has been hypothesized as a key factor in the generation of the pain sensation associated with migraine. The principal immune cell that responds to this inflammation is the parenchymal microglia of the central nervous system. Methods: Using a PET technique with 11 
disease, brain trauma, spinal cord injury, and multiple sclerosis (1, 2) . Neurogenic inflammation has been implicated as a key factor in the generation of the pain sensation associated with migraine headaches (3) (4) (5) . It is hypothesized that the proinflammatory peptides, such as substance P and calcitonin gene-related peptide, released from trigeminocervical nerve terminals in response to meningeal nociceptive stimuli, induce vasodilation and plasma protein extravasation. Such neurogenic inflammatory reactions were thought to trigger headache via a stimulation of trigeminal afferents (4, 5) . Consistent with this theory, vasogenic leakage (6, 7) and an increase in calcitonin generelated peptide in the jugular vein (8) have been reported in migraine patients during migraine attack. However, recent clinical trials have shown that several drugs that selectively inhibit plasma protein extravasation in rodents have failed to reduce pain severity in patients with migraine (9) . These observations indicate that a noninvasive evaluation method for neuroinflammation is necessary to investigate whether and how the neuroinflammation is involved in migraine etiology and verify the extrapolated data from an animal study to the human condition.
As the principal immune cells in the central nervous system, the microglial cells are activated in response to such neurogenic inflammation. The process of microglial activation is thought to be related to an increase in the number of microglial cells and the expression of numerous proteins such as peripheral benzodiazepine receptor (PBR) (10) . The PBR, which is a mitochondrial outer membrane protein and is expressed at low levels in the normal brain on resting microglial cells and astrocytes, is known to be upregulated in the activated microglial cells (11) (12) (13) . 11 C-labeled PK11195, a ligand that specifically binds to PBR, has been used extensively for imaging of activated microglial cells by PET in several neurologic disorders, such as stroke (14) , multiple sclerosis (15) , Alzheimer disease (16) , Parkinson disease (17) , and Huntington disease (18) . However, no literature has described the microglial activation in the brain of migraine patients using PET with 11 C-PK11195. Cortical spreading depression, described first by Leao (19) in 1944, is implicated in the pathogenesis of migraine. Cortical spreading depression is characterized by the spreading of neuronal or glial membrane depolarization accompanied by temporal elevation of the cerebral blood flow (CBF) throughout the cerebral cortical hemisphere at a rate of 2-5 mm/min (20, 21) . The rate of spread correlates with the observed spread of the aura of classic migraine (22) , which is characterized by either a paracentral scotoma or a small scintillating area of bright light. A spreading oligemia has been observed at a similar velocity during migraine attacks in experimental cortical spreading depression models (23, 24) . Hadjikhani et al. (25) also reported that a neurovascular event closely resembling cortical spreading depression has been shown with functional MRI during the migraine visual aura. On the basis of these observations and other experimental data, the cortical spreading depression has been hypothesized as an endogenous event involved in migraine etiology (26, 27) . In this study, we used 11 C-PK11195 PET to investigate the neurogenic inflammation in the cerebral cortex induced by unilateral cortical spreading depression.
MATERIALS AND METHODS
All experimental protocols were approved by the Ethics Committee on Animal Care and Use of the Institute of Physical and Chemical Research and were performed in accordance with the Guide for the Care and Use of Laboratory Animals (28) .
) was obtained from Advanced Biochemical Compounds (ABX). 11 Clabeled PK11195 was synthesized according to the procedures described by Shah et al. (29) , with slight modifications. Briefly, 1 mg of (R)-N-desmethyl-PK11195 was dissolved in 200 mL of anhydrous dimethyl sulfoxide, containing 1 mg of KOH. After trapping of the 11 C-CH 3 I, the vial was heated at 90°C for 4 min. Purification was performed by high-performance liquid chromatography on a COSMOSIL C 18 -AR-II column (10 · 250 mm, 5-mm particle size) (Nakalai) using acetonitrile:water (70:30) as the mobile phase. The purified fraction was evaporated to dryness and reconstituted with 4 mL of a saline solution including 0.3 mL of propylene glycol and 0.05 mL of polysorbate 80. The specific activity ranged from 30 to 70 GBq/mmol. Radiochemical purity was higher than 99%.
Animal Preparation for Generation of Spreading Depression
Male Sprague-Dawley rats (SLC), weighing approximately 300 g, were used. To prepare the spreading depression rat model, the head of each rat was fixed in a stereotactic apparatus (type 1430, David Kopf) under 1.5% isoflurane anesthesia. A thermocouple probe was connected with a thermocontroller and inserted into the rectum to maintain the body temperature at 37°C. A small burr hole was drilled in the skull at the frontal cortex (2.0-3.0 mm anterior and 2.0-3.0 mm lateral to the bregma). A glass micropipette (internal diameter of the tip, 50 mm) was inserted 1 mm below the cortical surface through the burr hole for subsequent microinjection. Two hours after the insertion, a microinjection of 1 M KCl was performed (at a rate of 0.2 mL/min for 1 min) every 10 min for a period of 2 h (12 injections; 2.4 mL of total volume). Sham controls (n 5 4 animals) were injected with 1 M NaCl at an analogous rate, duration, and frequency.
A laser Doppler flowmetry (LDF) (type FLO-N1; v-wave) probe was stereotactically placed in the parietal cortex over the skull for recording changes in CBF. The absolute value from LDF does not mean actual perfusion units; therefore, relative change in CBF is displayed (the data are normalized to prelevel).
PET Studies
Rats (n 5 39) were anesthetized and maintained with a mixture of 1.5% isoflurane and nitrous oxide and oxygen (7:3) and positioned in the gantry of a PET scanner (microPET Focus 220; Siemens Co., Ltd.). After a bolus injection of 11 C-PK11195 (;100 MBq per animal) via a tail vein, a 60-min emission scan was performed with 400-650 keV as the energy window and 6 ns as the coincidence time window. Unlabeled ligands (n 5 4, 1 mg/ kg) were injected intravenously 20 min after the injection of radiotracers for the displacement experiment. Emission data were acquired in the list mode. The acquired data were sorted into single sinogram (for static image) and dynamic sinograms (6 · 10 s, 6 · 30 s, 11 · 60 s, and 15 · 180 s, for a total of 38 frames). The data were reconstructed by standard 2-dimensional filtered backprojection (FBP) with ramp filter and cutoff frequency at 0.5 cycles per pixel or by a statistical maximum a posteriori probability (MAP) algorithm (12 iterations with point spread function effect). Compared with FBP, MAP-reconstructed images have been shown to result in improved spatial resolution and noise properties on small-animal PET images, an advantage for image coregistration. Meanwhile, FBP-reconstructed images were used for quantification. The radioactivity concentrations were normalized with cylinder phantom data and were expressed as standardized uptake values.
Image Analysis
A 3-dimensional T2-weighted MRI template, which was aligned in space with the rat brain atlas of Paxinos (30), was used for defining regions of interest (ROIs). PET images were manually coregistered with the MRI template using an imageprocessing small-animal PET software package (ASIPro 6.05; Siemens Co., Ltd.). ROIs were defined for each rat on the region of microinjection (core, as delineated by the hypersignal seen in the MAP-reconstructed image), ipsilateral surrounding areas (ipsilateral), and corresponding contralateral areas (contralateral, as shown in ½Fig: 1 Fig. 1 ). Each region was primarily drawn on coronal slices and then confirmed on sagittal and horizontal slices. All related ROIs were stacked into the volume of interest (VOI), and the mean value in each VOI was used to generate regional timeactivity curves.
Radioactivity and Metabolite Analysis in Plasma
Arterial blood was collected from the femoral artery at 10, 20, 30, 40, 50, and 60 s and 2, 5, 10, 25, and 40 min after administration. The radioactivity of blood and plasma was measured by a well-type g-counter (Wallac1470; PerkinElmer) and corrected for decay. For the metabolite analysis, plasma jnm066498-pm n 10/13/09
samples (1, 2, 5, 10, 25, and 40 min after administration) were extracted by acetonitrile, and the extracts were applied to an RP-18 thin-layer chromatography (TLC) plate (Merck). The plate was developed with acetonitrile:water (70:30) as the mobile phase. After migration, the TLC plates were dried and exposed on imaging plates (BAS TR2040; Fuji Photo Film) for 40 min. The signal of radioactivity on the imaging plates was measured with a digital PSL autoradiography analyzer (FLA-7000; Fuji Photo Film), and the data were estimated using imaging-analysis software (MultiGauge; Fuji Photo Film).
Kinetic Analysis
Kinetic modeling was performed using the PMOD software package (version 2.85; PMOD Technologies). A metabolitecorrected plasma input function was obtained by fitting to an exponential function, as follows. The 11 C-PK11195 parent fraction in the plasma samples for each sampling point was multiplied by this exponential function to obtain the metabolite-corrected plasma input function. The metabolite-corrected plasma timeactivity curves were fitted to 2 exponential functions to obtain the plasma pharmacokinetic parameter. The standard input function was obtained by averaging individual input functions from 3 satellite rats, and k 2 9 of the reference region (contralateral hemisphere), which represents the clearance from the reference region into the vascular compartment, was obtained using a 1-tissue-compartment model for each animal imaged. The averaged k 2 9 estimated in this study was 0.14/min. Binding potential (BP) was calculated for ipsilateral ROI kinetics using Logan noninvasive graphical analysis (31) , which was applied to the target regions by the following equation:
where C(T) is the radioactivity concentration in the tissue of interest, and C9(T) is the radioactivity concentration in the reference tissue (contralateral ROI). DVR is the distribution volume ratio calculated by the regression slope, int9 is an intercept that becomes constant after an equilibration, and k 2 9 is the average tissue-to-plasma clearance, which has to be determined before this analysis. In this study, k 2 9 was determined directly using the standard input function as shown above. Finally, BP is evaluated as BP 5 DVR -1.
Immunohistochemistry
The level of microglial activation was investigated by immunohistochemistry in the spreading depression-generated (n 5 4) and sham control (n 5 4) rats at 8 d after the operation. After the PET scan, the rats were anesthetized and perfused with 4% formaldehyde buffered with 0.1 M phosphate-buffered saline (pH 7.4). The brain was removed and further fixed in the same fixative at 4°C for 24 h. We prepared coronal brain sections (30-mm thickness) using a cryostat. To immunostain the microglial cells, mouse monoclonal antibody against rat OX-42 (1:100; Abcam) was used. The bound antibodies were visualized by the avidin-biotin complex method (Vectastain ABC kit; Vector) with 3, 39-diaminobenzidine.
Data Analysis
All results were expressed as mean 6 SD. The statistical differences in BP values between spreading depression-generated and sham-operated groups were assessed by 2-tailed unpaired t test. The statistical significance was set at P less than 0.05.
RESULTS

Spreading Depression in Rat Cerebral Cortex
Occurrence of cortical spreading depression in all rats used for the PET study was evaluated by transient CBF hyperperfusion recorded continuously from the ipsilateral hemisphere (7 mm posterior to the injection site). Transient CBF hyperperfusion always occurred after microinjection of 1 M KCl (at a rate of 0.2 mL/min for 1 min) in the ipsilateral hemisphere ( ½Fig: 2 Fig. 2) , as is characteristic of spreading depression (21) . Such transient CBF hyperperfusions are well known to be synchronously accompanied by the transient negative shifts of direct current (DC) potential, as described in our previous report (21) and in other literature (32) . The mean number of transient hyperperfusions in the KCl-treated rats (n 5 35) was 12.8 6 3.3 over 2 h. However, microinjection of 1 M NaCl (n 5 4) in an analogous fashion did not induce similar changes in CBF, indicating that cortical spreading depression was not induced in those rats.
PET Studies
To investigate the neurogenic inflammation after cortical spreading depression, we examined microglial activation using 11 C-PK11195 PET at 1, 3, 8, and 15 d after induction of unilateral cortical spreading depression in the rats. The radioactivity of 11 C-PK11195 was barely observed within the brain under normal condition in the control rats, except for the cerebral ventricles, including the lateral ventricle, third ventricle, and fourth ventricle (data not shown). In the cortical spreading depression-generated rats, 11 C-PK11195 radioactivity was high in the ipsilateral hemisphere, as compared with that in the contralateral hemisphere. The 11 C-PK11195 radioactivity was detectable in the injection site 1 d after the KCl treatment, and that increased and spread extensively in the ipsilateral surrounding areas at 3, 8, and 15 d after the KCl treatment (Figs. 1 and ½Fig: 3
3). Figure 1 shows a representative 11 C-PK11195 PET image coregistered with the corresponding MR image at 8 d after the KCl treatment. The highest radioactivity was seen in the KCl-microinjected site (core), and moderate radioactivity was observed in the ipsilateral surrounding areas but not in the corresponding contralateral areas (Fig. 1) . In the sham control rats, however, a slight increase in 11 C-PK11195 radioactivity was seen primarily in the NaCl-microinjected site at 8 d after the sham operation.
The temporal changes of 11 C-PK11195 uptake in the core, ipsilateral, and contralateral ROIs were similar (Fig. 3) . The radioactivity of 11 C-PK11195 in the contralateral ROI reached a peak within the first minute after radiotracer injection and decreased rapidly thereafter. In the cortical spreading depression-generated rats, the decrement in the ipsilateral areas (core and ipsilateral ROIs) was slower than that in the contralateral areas (contralateral ROI). The obvious contrast of radioactivity between ipsiand contralateral hemispheres appeared first 3 d after the operation and remained until the end of the study (Fig. 3) . No obvious contrast between the 2 hemispheres was observed in the sham-operated control rats at 8 d after the NaCl treatment.
In vivo displacement was performed by injecting unlabeled PK11195 (n 5 4, 1 mg/kg) at 20 min after the injection of 11 C-PK11195 ( ½Fig: 4 Fig. 4 ). Immediately after injection of unlabeled PK11195, the brain uptake of 11 C-PK11195 was transiently increased in both ipsiand contralateral hemispheres because of a release of 11 C-PK11195 from peripheral organs into the blood circulation, as previously reported (33, 34) . The contrast of radioactivity between the 2 hemispheres completely disappeared after the unlabeled PK11195 injection, indicating 11 C-PK11195 was rapidly displaced by unlabeled PK11195 in the ipsilateral hemisphere.
Using Logan noninvasive graphical analysis, we estimated the BP value for 11 C-PK11195 in the core and ipsilateral ROIs. The BP values in the core and ipsilateral ROIs were increased with the time after the KCl treatment ( ½Fig: 5 Fig. 5 ). In the cortical spreading depression-generated rats, the mean value of BP in the core ROI reached 0.45 6 0.10 (n 5 5) at 3 d after the KCl treatment and maintained approximately the same level until 15 d (0.51 6 0.36, n 5 5). The mean values in the ipsilateral ROI were approximately half of those in the core ROI at each time of the examination, indicating that microglial activation was outstanding in the microinjected site. In contrast with the cortical spreading depression-generated rats, the BP values were lower in the sham-operated control (NaCl treatment) rats. Significant differences between spreading depressiongenerated and sham control rats were noted in both ROIs at 8 d after the operation (core, 0.48 6 0.18 vs. 0.21 6 0.05, and ipsilateral, 0.26 6 0.07 vs. 0.14 6 0.08, in the spreading depression-generated [n 5 11] and sham control [n 5 4] rats, respectively; P , 0.05, unpaired t test) ( ½Fig: 6 Fig. 6 ).
Immunohistochemical Studies
The activation of microglial cells was confirmed by immunohistochemical studies after the induction of spreading depression. As shown in ½Fig: 7 Figure 7 , a large number of immunosignals of OX-42 were observed in the ipsilateral hemisphere, compared with the corresponding area of the contralateral hemisphere, in the rats 8 d after unilateral spreading depression generation. Magnified photomicrographs taken from the corresponding parietal cortex showed that hypertrophied (enlarged, darkened soma with shorter, thicker processes) or ameboid (densely stained, enlarged soma with a few short processes) OX-42-positive microglial cells were often seen in the ipsilateral hemisphere (Fig. 7C) . However, such a difference between the 2 FIGURE 2. Cortical spreading depression-associated CBF changes in experimental and sham-operated rat. Dynamic changes in CBF were continuously recorded from parietal cortex over skull using LDF. Upper panel shows a representative CBF change recorded from parietal cortex in KClmicroinjected rat. Lower panel shows result from a rat who received NaCl microinjection using analogous paradigm, as sham operation. Arrows at bottom of each panel indicate time of microinjection. Note that spreading depressionassociated CBF hyperperfusions were not observed in sham-operated rat.
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hemispheres was not observed in the rats treated with NaCl as a sham operation.
DISCUSSION
Neurogenic inflammation is thought to be a key factor in the generation of pain sensation in migraine headaches. In the present study, we evaluated neurogenic inflammation using an animal model of migraine and noninvasive PET. Our results show that in the unilateral spreading depression model rats, the uptake of 11 C-PK11195, a PET tracer for PBR, which is used extensively to image activated microglial cells in the central nervous system, was increased in the ipsilateral hemisphere and completely displaced by excess unlabeled ligands. In addition, quantitative analysis in spreading depression model rats, compared with that in the sham-operated control rats, showed that the BP values in the core and ipsilateral ROIs were significantly high. Finally, predominant microglial activation in the ipsilateral cerebral hemisphere of the spreading depression model rats was also confirmed by immunohistochemical study. These observations suggest that an inflammatory process may be involved in the pathologic state of migraine and that 11 C-PK11195 PET is a useful tool for evaluating the neurogenic inflammation in vivo.
On the basis of the expression pattern of the PBR in the pathophysiologic state, 11 C-labeled PK11195 has been developed as a specific PET ligand for the PBR to image activated microglial cells in the brain (15, 17, 35, 36) . The PBR is known to be highly expressed in activated microglial cells under neuropathologic conditions but barely expressed in healthy brain tissue (12, 13) . The upregulated level of PBR was known to be well correlated with the state of microglial activation (15, 37, 38) . In the present study, we used unilateral cortical spreading depression as an animal model of migraine and demonstrated that the brain uptake of 11 C-PK11195 was specifically increased in the ipsilateral hemisphere. It is well known that cortical spreading depression-induced pathophysiologic changes, such as transient CBF hyperperfusion, negative DC potential shifts, and related biochemical events, are restricted to the ipsilateral hemisphere (19, 21, 39) . Consistent with these characteristics of spreading depression, we demonstrated that micro- jnm066498-pm n 10/13/09 glial reactivity, indicated by immunosignal of OX-42, was observed predominantly in the ipsilateral hemisphere after cortical spreading depression. Indeed, Caggiano et al. (40) have also reported that reactive microglial cells appeared predominantly in the ipsilateral hemisphere after KClinduced unilateral neocortical spreading depression by the immunohistochemical approach. Moreover, our displacement experiment demonstrated that such a superior brain uptake of 11 C-PK11195 in the ipsilateral hemisphere was completely displaced by excess unlabeled ligands. Though astrocytes have also been reported to express PBR in vitro (41), the origin of 11 C-PK11195 radioactivity in vivo is thought to be primarily from activated microglial cells in the brain (15, 35, 36) . Therefore, the increased radioactivity of 11 C-PK11195 in the ipsilateral hemisphere may originate from the activated microglial cells in response to the neurogenic inflammation after the unilateral spreading depression.
In the present study, BP value for 11 C-PK11195 was estimated using the Logan noninvasive graphical analysis (31) . The mean BP value for 11 C-PK11195 was approximately 0.5 in the core ROI after spreading depression generation. That value was slightly lower than that reported in the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-induced lesion area of the rat striatum (0.66 6 0.15), in which the BP value was estimated by a simplified reference tissue model (33) . Using the simplified reference tissue model, Cagnin et al. also have reported that mean BP value for 11 C-PK11195 in the cerebral cortex of healthy volunteers was 0.13 6 0.04 and increased variably (#0.79) in several cortical regions of patients with herpes simplex encephalitis (36) . In the present study, the highest value of mean BP for 11 C-PK11195 was noted in the KClmicroinjected site (0.48 6 0.18), and a moderate value was observed in the surrounding area of the injection site (0.26 6 0.07) 8 d after the unilateral spreading depression generation. In contrast, the BP value in the ipsilateral hemisphere of sham-operated rats was 0.14 6 0.08, which was almost equivalent to the value reported by Cagnin et al. for the cerebral cortex of healthy volunteers. (36) . These 
CONCLUSION
In the present study, we evaluated for the first time, to our knowledge, the neurogenic inflammation in the rat model of migraine using quantitative PET with 11 C-PK11195. The microglial activation quantified by 11 C-PK11195 PET was significantly increased in the cerebral hemisphere, which underwent unilateral cortical spreading depression. These results suggest that 11 C-PK11195 PET is useful for the evaluation of the neurogenic inflammatory process and may provide a new and powerful tool for both the diagnosis of migraine and the monitoring efficacy for migraine therapy. jnm066498-pm n 10/13/09
